"I think Pete has a point In his weak dosage theory and maybe we will learn something from the compassionate care patient data."
I'll probably need some help interpreting it, but I'd sure like to see how the dosages in the trial and the resultant efficacy data stack up against the compassionate use dosages and their resulting efficacy data.
1. When do you think we'll see those numbers? The rules call for their submission by July 1. 2. Why do you think we haven't seen them already?
The "weak dosage theory" (aka the weak dosage excuse) will last until the data is revealed, maybe longer.